Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study Patients were randomly assigned to 39 weeks of VAC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results